Waldencast plc (WALD)
NASDAQ: WALD · Real-Time Price · USD
1.970
+0.190 (10.67%)
At close: Sep 17, 2025, 4:00 PM EDT
1.880
-0.090 (-4.57%)
After-hours: Sep 17, 2025, 5:41 PM EDT
Waldencast Revenue
In the year 2024, Waldencast had annual revenue of $273.87M with 25.55% growth. Waldencast had revenue of $142.29M in the half year ending December 31, 2024.
Revenue (ttm)
$273.87M
Revenue Growth
+25.55%
P/S Ratio
0.81
Revenue / Employee
$817,516
Employees
335
Market Cap
241.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 273.87M | 55.73M | 25.55% |
| Dec 31, 2023 | 218.14M | 52.01M | 31.30% |
| Dec 31, 2022 | 166.13M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Berkshire Hathaway | 370.15B |
| JPMorgan Chase & Co. | 163.75B |
| Bank of America | 98.46B |
| Wells Fargo & Company | 77.62B |
| Morgan Stanley | 65.61B |
| American Express Company | 63.44B |
| HSBC Holdings | 56.21B |
| The Goldman Sachs Group | 54.79B |
WALD News
- 7 days ago - Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand - GlobeNewsWire
- 4 weeks ago - Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation - GlobeNewsWire
- 4 weeks ago - Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
- 2 months ago - Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand - GlobeNewsWire
- 3 months ago - Waldencast: Learning To Grow Hurts Sometimes - Seeking Alpha
- 4 months ago - Waldencast plc (WALD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Waldencast Reports Q1 2025 Financial Results - GlobeNewsWire
- 4 months ago - Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast - GlobeNewsWire